檢索結果 - Chingiz Underbayev
- Showing 1 - 8 results of 8
-
1
-
2
Systemic in vivo lentiviral delivery of miR-15a/16 reduces malignancy in the NZB de novo mouse model of chronic lymphocytic leukemia 由 Siddha Kasar, Erica Salerno, Yuan Yao, Chingiz Underbayev, Dan Vollenweider, María Fernanda Lucatelli Laurindo, Helen Fernandes, Désirée Bonci, Antonio Addario, Fermina M. Mazzella, Elizabeth Raveché
出版 2011Artigo -
3
A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era 由 Hannah R. Robinson, Junpeng Qi, Erika M. Cook, Cydney Nichols, Eman L. Dadashian, Chingiz Underbayev, Sarah E. M. Herman, Nakhle S. Saba, Keyvan Keyvanfar, Clare Sun, Inhye E. Ahn, Sivasubramanian Baskar, Christoph Rader, Adrian Wiestner
出版 2018Artigo -
4
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia 由 Nakhle S. Saba, Deanna H. Wong, Georges Tanios, Jessica R. Iyer, Patricia Lobelle‐Rich, Eman L. Dadashian, Delong Liu, Lorena Fontán, Erik K. Flemington, Cydney Nichols, Chingiz Underbayev, Hana Safah, Ari Melnick, Adrian Wiestner, Sarah E. M. Herman
出版 2017Artigo -
5
CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy 由 Anfal Alsadhan, Jonathan Chen, Erika M. Gaglione, Chingiz Underbayev, Pamela L. Tuma, Xin Tian, Lita A. Freeman, Sivasubramanian Baskar, Pia Nierman, Susan Soto, Andy Itsara, Inhye E. Ahn, Clare Sun, Elena Bibikova, Tanja Nicole Hartmann, Maissa Mhibik, Adrian Wiestner
出版 2023Artigo -
6
Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma 由 Nakhle S. Saba, Delong Liu, Sarah E. M. Herman, Chingiz Underbayev, Xin Tian, David Behrend, Marc A. Weniger, Martin Skarzynski, Jennifer Gyamfi, Lorena Fontán, Ari Melnick, Clíona Grant, Mark Roschewski, Alba Navarro, Sı́lvia Beà, Stefania Pittaluga, Kieron Dunleavy, Wyndham H. Wilson, Adrian Wiestner
出版 2016Artigo -
7
Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia 由 Inhye E. Ahn, Chingiz Underbayev, Adam Albitar, Sarah E. M. Herman, Xin Tian, Irina Marić, Diane C. Arthur, Laura Wake, Stefania Pittaluga, Constance M. Yuan, Maryalice Stetler‐Stevenson, Susan Soto, Janet Valdez, Pia Nierman, Jennifer Lotter, Liqiang Xi, Mark Raffeld, Mohammed Farooqui, Maher Albitar, Adrian Wiestner
出版 2017Artigo -
8
The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy 由 Dan A. Landau, Clare Sun, Daniel Rosebrock, Sarah E. M. Herman, Joshua Fein, Mariela Sivina, Chingiz Underbayev, Delong Liu, Julia Hoellenriegel, Sarangan Ravichandran, Mohammed Farooqui, Wandi Zhang, Carrie Cibulskis, Asaf Zviran, Donna Neuberg, Dimitri Livitz, Ivana Božić, Ignaty Leshchiner, Gad Getz, Jan A. Burger, Adrian Wiestner, Catherine J. Wu
出版 2017Artigo
相關主題
Immunology
Biology
Cancer research
Chronic lymphocytic leukemia
Leukemia
Ibrutinib
Medicine
Antibody
Bruton's tyrosine kinase
Gene
Genetics
Receptor
Tyrosine kinase
B cell
Internal medicine
B-cell receptor
Cancer
Immune system
Immunotherapy
In vivo
Mutation
Somatic evolution in cancer
breakpoint cluster region
microRNA
Antigen
Autoantibody
Autoimmune disease
Biochemistry
Bioinformatics
Biotechnology